home / stock / delcf / delcf news


DELCF News and Press, Delic Holdings From 01/10/22

Stock Information

Company Name: Delic Holdings
Stock Symbol: DELCF
Market: OTC
Website: deliccorp.com

Menu

DELCF DELCF Quote DELCF Short DELCF News DELCF Articles DELCF Message Board
Get DELCF Alerts

News, Short Squeeze, Breakout and More Instantly...

DELCF - Delic Corp CEO to Participate in HC Wainwright Bioconnect Virtual Conference January 2022 Investor Conference

Delic Corp CEO to Participate in HC Wainwright Bioconnect Virtual Conference January 2022 Investor Conference Canada NewsWire Matt Stang , Co-founder and CEO of Delic Corp, Will Present the Company's Strategic Outlook During the Conference, Jan 10-13 VANC...

DELCF - A Recap of How Psychedelics Fared in 2021

At the start of last year, only a few psychedelic companies were trading on the exchange markets , with Compass Pathways (NASDAQ: CMPS) and Mind Medicine (NASDAQ: MNMD) (NEO: MMED)  (“MindMed”) among them. However, this year saw a number of IPOs, which increased the to...

DELCF - PsychedelicNewsBreaks - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Expanding Presence, Access Within Psychedelic Wellness Space

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, recently sought to expand its presence within psychedelic wellness, entering into a merger agreement with Ketamine Wellness Centers LLC (“KWC”). KWC boasts the nation’s largest chain ...

DELCF - Study Finds That Psilocybin's Therapeutic Effect Isn't Altered by SSRI Medication

Compass Pathways recently released data that shows that selective serotonin reuptake inhibitor (“SSRI”) drugs can be used together with psilocybin. SSRI drugs are commonly used to treat mental health conditions including anxiety and depression. Estimates show that more th...

DELCF - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO Joins Gamechangers LIVE Podcast; Shares Views on the Evolution of the Psychedelics Industry

Delic Corp is a leading psychedelic wellness platform with a business network which includes psychedelic wellness clinics, psilocybin research facilities, a famed psychedelic wellness event, and dedicated media and e-commerce platforms Delic’s CEO, Matt Stang recently joined the ...

DELCF - Congressman Calls on Colleagues to Urge DEA to Permit Psilocybin Access

Rep. Earl Blumenauer is asking fellow legislators to join him in urging the DEA to permit patients suffering from terminal illnesses to use psilocybin as part of their treatment, without fear of being federally prosecuted. In a letter circulated by Blumenauer, he notes that there are feder...

DELCF - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) to Open 2 New Ketamine Infusion Clinics; Co-Founder and CEO Matt Stang Reveals Investor Relations Efforts

Delic Holdings subsidiary, Ketamine Wellness Centers, announced plans to open two new clinics in the coming weeks The clinics, to be located in Salt Lake City, Utah and Reno, Nevada will take KWC’s total clinic count to 14, forming part of the company’s plan to open 13 new...

DELCF - PsychedelicNewsBreaks - Delic Holdings Corp.'s (CSE: DELC) (OTCQB: DELCF) Flagship Event Provides Pioneering Insights into Business, Psychedelics, Overall Wellness

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, held the Meet Delic Conference in November in Las Vegas, Nevada. The event, which featured over 60 thought leaders, medical professionals and wellness advocates, drew more than 2,500 attendees, becoming t...

DELCF - Study Finds Psychedelic Substances Improve Mental Health by Increasing Emotion Regulation

Findings from a new study show that the use of psychedelics may improve an individual’s mental health . The research, which was published in the “Journal of Humanistic Psychology,” discovered evidence of a pathway that facilitates the increase of spirituality after usin...

DELCF - Survey Finds That Parents are Open to Ketamine Treatment for Adolescents

A new survey has found that most parents are accepting of the use of ketamine therapy with adolescents to treat bipolar disorder, major depressive disorder and suicidal ideation. This first-of-its-kind study assessed the attitudes of parents toward the use of ketamine as a treatment for ad...

Previous 10 Next 10